Microperimetry is a novel technique for assessing visual function and appears particularly suitable for age-related macular degeneration (AMD). Compared to standard automated perimetry (SAP), microperimetry offers several unique features. It simultaneously images the fundus, incorporates an eye tracking system to correct the stimulus location for fixation loss and identifies any preferred retinal loci. A systematic review of microperimetry in the assessment of visual function in AMD identified 680 articles; of these, 52 met the inclusion criteria. Microperimetry and AMD is discussed in relation to: disease severity; structural imaging outcomes; other measures of visual function; and evaluation of the efficacy of surgical and/ or medical therapies in clinical trials. The evidence for the use of microperimetry in the functional assessment of AMD is encouraging. Disruptions of the ellipsoid zone (EZ) band and retinal pigment epithelium (RPE) are clearly associated with reduced differential light sensitivity (DLS) despite the maintenance of good visual acuity (VA). Reduced DLS is also associated with outer segment thinning and RPE thickening in early AMD and with both a thickening and a thinning of the whole retina in CNV. However, microperimetry lacks the robust diffuse and focal loss age-corrected probability analyses associated with SAP and the technique is currently limited by this omission. the maintenance of good visual acuity . Reduced DLS is also associated with outer segment thinning and RPE thickening in early AMD and with both a thickening and a thinning of the whole retina in choroidal neovascularization. Microperimetry, however,lacks the robust diffuse and focal loss age-corrected probability analyses associated with SAP, and the technique is currently limited by this omission.
I. Introduction
Age-related macular degeneration (AMD) 1 is the leading cause of blindness in the developed world 66 and accounts for the majority of registerable visual impairment in both the USA and the UK 10, 37, 54 . Visual acuity (VA) is the most widely used outcome measure in ophthalmic research; however, VA is insufficiently sensitive to detect the early stages of functional loss in AMD 42, 50 . Various other tests of visual function, such as dark adaptation 46 , flicker threshold 15 and photostress recovery time 44 are more sensitive than VA in detecting early functional loss in AMD; however, such tests have limited clinical utility because they are time-consuming 44 . There is, therefore, a need for a robust and clinically appropriate technique to assess visual function across the macula that is more indicative than VA.
Microperimetry is similar to standard automated perimetry (SAP) in that it measures the differential light sensitivity (DLS), i.e. the minimum luminance of a white spot stimulus superimposed upon a white background of uniform luminance necessary to perceive the stimulus. Microperimetry, however, is novel in that it uses an eye tracking system to correct the position of the stimulus for any changes in fixation. Such a correction is particularly appropriate in the later stages of macular disease where unsteady fixation and/ or a preferred retinal locus are common. Microperimetry offers the additional benefit of providing a real-time en-face image of the posterior pole. The latter is of value in macular disease as it enables Mean Sensitivity (MS) is the most common outcome measure in microperimetry and is defined as the mean of the DLS obtained across all the designated stimulus locations; however, the MS is a summary measure and does not account for the decline in DLS with age. Less common, but more appropriate, outcome measures for microperimetry are the Total Deviation (TD), defined as the difference between the DLS at a given stimulus location and the corresponding age-corrected normal value, and the Mean Deviation (MD), defined as the arithmetic mean of the TD obtained across all the designated stimulus locations. A worsening of visual function is indicated by an increasingly less positive MS and by an increasingly negative TD and MD.
Given that the microperimetry is novel and that the design features appear particularly suitable for assessing visual function in AMD, we undertook a systematic review to evaluate the literature relating to the use of microperimetry for assessing visual function in AMD.
II. Results
The search identified 674 primary articles. Six additional articles were obtained from the references within the primary retrieved articles. The final number of included articles was 52
( Figure 1 ).
We divided our review into four principle areas that reflected the content of the included articles: evaluation of the efficacy of microperimetry in distinguishing between the various stages of AMD severity (4 articles), the relationship between microperimetry outcomes and structural imaging outcomes (including Spectral Domain Optical Coherence Tomography, SD-OCT) (21 articles), the relationship between microperimetry outcomes and those of other measures of visual function (12 articles), and microperimetry outcomes in the evaluation of the efficacy of medical therapy and/ or surgical intervention in the treatment of AMD (17 articles).
A.
Quality of evidence
The quality of each of the 52 included articles is described in Table 1 , which is ordered by quality of evidence. The studies were classified as either experimental or observational. Within these two classifications, experimental studies were classified as either randomised control trial (RCT) or as non-randomised design, which will be referred to as quasi-experimental.
Observational studies were classified as cross-sectional, case-controlled or case series. None of the included studies were cohort studies. Assessment of the quality of reporting showed that over half the articles included in this review had limitations relating to the quality of the microperimetry outcome (18 articles) and/ or to the reporting of the SD-OCT methods and analysis (11 articles). The reporting of microperimetry stimulus parameters was also generally poor, particularly in regard to the description of the stimulus program (i.e., the number, the location, and the separation, of the stimuli).
The method of classification of AMD severity varied between the various studies and limited the meaningful comparisons between studies. These comprised the AREDS grading system 7 (7 articles), the Beckman classification 19 (9 articles), the Wisconsin Age-related Maculopathy
Grading system 36 (1 article), and the International Classification and Grading system 8 (2 articles). Consequently, the classification method utilised in each study is noted, where appropriate, throughout this review.
Similarly, the difference in the stimulus parameters and also in the dynamic range between the various microperimeters used, hinder direct comparisons of DLS between studies 1 .
Microperimetry was undertaken by the Nidek MP1 or MP1-S in 29 of the 52 included articles 3, 5, 9, 12, 16, 17, 23, 25, [32] [33] [34] [35] 39, 41, 43, 45, 48, 49, 51, 52, [55] [56] [57] [59] [60] [61] [62] [63] 68 by the Nidek MP3 in 1 27 , by the MAIA in 13 4, 6, 11, 65, [69] [70] [71] [72] [73] [74] [75] [76] [77] , by the Optos Spectral OCT/SLO in 7 13, 20, [28] [29] [30] 38, 53 and by the Rodenstock SLO microperimeter in two articles 18, 22 . The limited dynamic range of the previously available Optos OCT SLO and Nidek MP-1 microperimeters arising from the lower maximum stimulus luminance results in ceiling and floor effects compared to the MAIA and MP-3 microperimeters 40 . In particular, the presence of a floor effect can result in underestimation of the depth of the field loss. Consequently, the type of microperimeter is specified whenever the perimetric outcome is given in decibels (dB).
B. Microperimetry and AMD severity
Four of the 52 included articles evaluated the efficacy of microperimetry in distinguishing between the various stages of AMD severity 16, 22, 65, 70 . 16 . For both these studies, the magnitudes of the group mean MS reflected the severity of the structural classification of AMD;
however, the magnitudes of the standard deviations associated with the group mean MS indicated overlap between groups. In addition, no criteria for microperimetry were given for the optimal differentiation, on an individual basis, between the AMD severities. The analysis of the DLS at each individual stimulus location enabled a localised assessment of function that was more descriptive of the AMD severity than that provided by the MS 70 .
The reduction in DLS varies with the location and severity of the AMD. Eyes with subfoveal neovascular AMD (nAMD) that exhibit severe (absolute) localised parafoveal abnormality (0 dB, as measured by an early commercially available Rodenstock SLO microperimeter;
Rodenstock GmbH, Munich, Germany) manifest a normal foveal DLS, enabling central fixation to be maintained 22 . The likelihood of a dense parafoveal abnormality increases as the duration of self-reported symptoms increases 22 .
In summary, the MS derived by microperimetry is reduced in eyes with AMD and is able to differentiate, on a group mean basis at least, between levels of disease severity 16, 65 accompanied with a wedge-shaped hyporeflective area in the OPL 78 . Finally, ORTs can only be visualised by SD-OCT and appear as a hyper-reflective ring with a hyporeflective center located within the outer nuclear layer ( Figure 5 ).
Retinal layers
The relationship between outer retinal layer thickness and DLS in early AMD has been investigated by comparing RPE and OS thicknesses at locations with and without an abnormal DLS (defined as a TD value with a probability of lying within the normal range of p≤ 0.05) 3 .
The OS layer was thinner at locations with an abnormal TD (p<0.01). The OS layer thickness was also significantly correlated with both MS and MD obtained using the MP-1 microperimeter (r=0.62 and r=0.63, respectively, both p<0.01) 3 . MS worsens with increased thickening of the RPE 3, 74, 76 . A 10μm increase in RPE layer thickness is associated with a 0.29 dB worsening of MS (p<0.001) obtained with the MAIA microperimeter 76 .
In eyes with early to intermediate AMD, the MS at locations overlying drusen is statistically significantly worse than that at adjacent locations 28, 34 . EZ band disruption is the strongest predictor of DLS at locations with drusen, 28 and the reduction in MS in the presence of EZ band disruption is worse than that in the presence of drusen alone 34 . Notably, in the former study the stage of AMD was not classified. Individuals exhibiting drusen (excluding nAMD)
were included and, therefore, any stage of AMD may have been involved 28 . In early to late atrophic AMD, MS worsens as the EZ band disturbance increases 38, 53, 74 . In nAMD, a worsening of EZ band disruption and an increase in central retinal thickness are both associated with a reduction in MS (r=-0.79; p<0.001 and r=-0.51; p<0.01, respectively) 38, 61 .
Similarly, in nAMD treated with bevacizumab, MS significantly worsened (p<0.01) with increase in EZ band disruption 29 . The presence of nAMD, intra-retinal cysts and a focal/ whether the greater reduction in the scotopic MS was caused by differences in the measurement range resulting from the two different background luminances enabling scotopic and mesopic viewing conditions. Scotopic dysfunction also correlates with outer retinal thickness in eyes with reticular pseudodrusen: a 1μm decrease in thickness corresponded to a 0.96dB reduction in scotopic MS 59 . In another study, the MS was also reduced in the presence of pseudodrusen in atrophy-free areas of eyes with GA 63 .
Reticular pseudodrusen

Geographic atrophy
In GA, MS has been compared between areas with and without either RPE loss and/ or photoreceptor damage 63 . The group mean MS, obtained with the MP-1 microperimeter, was markedly lower in areas of RPE loss (mean 1.84 dB; SD 2.68; p<0.001) and also in areas with photoreceptor damage (mean 6.57 dB; SD 4.13; p<0.001) when compared to areas without 63 . In GA, a thinning or an absence of the RPE, an absence of the external limiting membrane, and a thickening of the EZ boundary are each associated with absolute field loss (0dB)
obtained with the MP-1 microperimeter 57 . The group mean MS obtained with the MP-3 microperimeter at the GA boundary is lower (mean 13.7dB; SD 4.7) than the group mean MS in the area surrounding the GA (mean 20.8dB; SD 3.8); however, the latter is lower than that in eyes without GA (mean 23.9dB; SD 2.6) (p<0.001) 27 . Another study utilized en-face OCT to identify GA boundaries at the choroidal and the outer retinal levels. When the MS was better than 10dB, the mean area of GA was larger at the outer retinal level than at the choroidal level; however, the areas were similar when the MS was worse than 10dB 51 .
In areas of nGA, the group mean MS measured by MAIA microperimetry is reduced (mean 20.4 dB; SD 0.8) compared to areas without atrophy (mean 23.8 dB; SD 0.7, p<0.01) and is greater than that obtained in areas with drusen associated atrophy (mean 16.4 dB; SD 0.9; p<0.01) 73 . The area of drusen associated atrophy did not exhibit absolute loss as was the case in GA 73 .
Progression of GA can be monitored by fundus autofluorescence (FAF) as the areas of GA appear hypo-fluorescent. One study compared the outcome of MP-1 microperimetry to that from both near-infrared fundus autofluorescence (NIR-FAF) and short-wavelength FAF 52 . The associations between severe relative loss (a DLS of not more than 5 dB) and normal and hyper-fluorescence outcomes were determined for each FAF technique. It was concluded that the outcome from MP-1 microperimetry, in combination with both FAF techniques, allowed effective detection and monitoring of GA 52 . Another study used microperimetry to evaluate SD-OCT FAF and NIR-FAF 20 . As would be expected, DLS was substantially reduced in areas of GA, and the imaging techniques were able to detect the presence of GA with differing capabilities. SD-OCT was considered to be the most appropriate imaging technique to examine GA 20 .
Outer retinal tubulations
Outer retinal tubulations (ORTs) are not specific to AMD and are seen more commonly in inherited retinal disorders such as choroideremia and retinitis pigmentosa 24 . In AMD, they
are not a typical feature and can occur in eyes with previous nAMD. The identification of ORTs is clinically important as they may be misinterpreted as either intraretinal or subretinal fluid, with the resultant unnecessary treatment 33, 79 . In a study of individuals without ORTs who were treated for nAMD, the improvement in MS obtained with the MP-1 microperimeter after 45 .
In a separate study of individuals with intermediate stage AMD (Beckman classification 19 ),
neither MS nor foveal DLS were associated with a low luminance deficit (LLD)--defined as the difference between VA and LLVA--or with the self-reported outcome to a 10-item night vision questionnaire. Nevertheless, LLD was significantly associated with difficulty under low luminance levels 77 .
In individuals with nAMD who had previously received anti-VEGF therapy, MS (out to 20˚ eccentricity) was moderately correlated with both VA (r=0.54) and CS (r=0.53) separately and, to a lesser extent, with reading speed (r=0.37 all p<0.001) 56 . In those undergoing anti-VEGF treatment, however, no association was present between the MS and either VA or CS 30, 43 .
Other studies have shown that both DLS and VA improve up to either 6 months 48 or 12 months 43 of anti-VEGF therapy; however, the association between DLS and VA was not determined.
In subfoveal CNV, an increase in the area of absolute DLS loss is associated with a decline in both reading acuity (r=0.52; p=0.01) and reading speed (r=-0.48; p=0.02) 18 .
In GA manifesting absolute loss of DLS and a central island of residual vision (foveal sparing), the MS out to 20° eccentricity was moderately associated with reading speed (r²=0.5) 5 . As an improvement in reading is a major goal of vision rehabilitation, microperimetry provides additional information about the location and size of the area(s) of residual function, allowing for a realistic estimation of reading ability and the likely outcome of rehabilitation 5, 23 . increased, reaching a minimum of 7dB at a thickness of 320-339μm, and declined as the thickness decreased, reaching a minimum of 15dB at a thickness of <160μm 4 . These findings, however, cannot be compared with other studies as both the microperimetry and the method of measuring retinal thickness were not reported. A similar finding was noted with bevacizumab therapy: MS increased following a reduction in retinal thickness 29 and decreased with increasing retinal thickness (r=-0.54, p<0.01); 55 however, neither of these latter studies specified the thickness boundaries used in the retinal thickness measurements.
It has been suggested that the improvement in MS occurs from the reduction in RPE lesion area with treatment rather than from a reduction in the retinal thickness, as a whole 35 .
The relationship between DLS and specific AMD morphology, as identified by SD-OCT, has been studied in previously untreated patients with nAMD who subsequently received aflibercept 62 . The greatest improvement in DLS (measured with the MP-1 microperimeter), occurred 3 months after the start of therapy; areas exhibiting a reduction in either a serous PED or subretinal fluid exhibited the greatest improvement in group mean MS of 5.5dB and 4.0dB respectively (p<0.001). Areas with fibrovascular PED or with an intra-retinal cystoid space also improved, but to a lesser extent (group mean improvements 2.3dB and 1.7dB, respectively) 62 . In an earlier study, DLS improved following ranibizumab therapy in previously untreated patients with nAMD. The most marked improvement occurred at stimulus locations which were associated with a reduction in subretinal fluid, intraretinal fluid or intraretinal cystoid space 60 .
Although all trials of anti-VEGF therapy involving microperimetry report an improvement in DLS from baseline, the results of these studies are equivocal with respect to the duration of therapy beyond which the DLS ceases to improve. A number of studies have found that DLS continues to improve up until 12 months, the time at which the studies ended 13, 25, 39, 43, 60 ;however, two studies suggest that DLS does not improve beyond that recorded after one week of treatment 9, 35 . DLS can also decline following withdrawal of anti-VEGF therapy.
Individuals with stable nAMD, who ceased anti-VEGF therapy, exhibited a reduction in DLS during the follow-up period (at least 3 visits over 7 months) when compared with those that continued to receive treatment 4 . It was speculated that the reduction in DLS may have resulted either from photoreceptor atrophy over time that was too subtle to be identified by VA or that CNV could be occurring at a subclinical level below that required by the United Kingdom NICE guidelines for an anti-VEGF injection 4 .
Two trials with unsuccessful outcomes utilized microperimetry as an outcome measure. One assessed the outcome of transpalpebral electrotherapy as a treatment for early to intermediate AMD (AREDS grade 2, 3 and 4 7 ), and the another evaluated the outcome of photodynamic therapy combined with intravitreal triamcinolone as a treatment for nAMD 6, 17 . Neither study found a sustained improvement in either DLS, VA, or CS, following treatment.
Macular translocation surgery (MT360) involves a peripheral retinectomy of 360˚ at the ora serata, following which the subfoveal CNV is removed and the whole retina is rotated such that the fovea is located away from the removed CNV. The retina is then reattached. In one study, distance VA, near VA, and reading speed improved post-operatively 12 . DLS was specified in terms of the median retinal sensitivity score (MRSS) obtained with the MP-1 microperimeter. The 12 month post-operative group mean MRSS was better (2.5dB, SD 4.3)
in the foveal surgical area compared to the retinal area where the CNV had been removed (<0dB) 12 ; however, the MRSS had not been evaluated prior to surgery; therefore it is not possible to evaluate whether the surgery improved visual function. Another study found that the MRSS only improved in lesions greater than 4 disc areas 41 ; however, the two studies evaluated the outcome of the translocation surgery by differing methods. The first determined the MRSS at areas of healthy retina compared to that at the surgical sites 12 , whereas the second compared the difference in the MRSS for the pre-and 12-month post-operative areas 41 .
Two RCTs examined the effect of lutein supplementation on macular pigment optical density and the subsequent effect on visual function. One RCT found that, although lutein supplementation increased the macular pigment density, there was no improvement in MS after 6 months of lutein supplementation 68 . Macular pigment density was also weakly correlated with DLS (r =0.25, p =0.027) 68 . The second RCT examined differing levels of lutein supplementation (10mg, 20mg and a combination of lutein with zeaxanthin) with placebo. After two years of supplementation, the group mean MS, obtained with the MP-1 microperimeter, was greater for the groups receiving 10mg (13.37 dB) or 20 mg of lutein (12.55 dB) compared to the control group (10.32 dB, p<0.05) 32 .
It is clear that microperimetry has the ability to detect changes in visual function arising from a variety of interventions for AMD. All studies suggest that MS improves following anti-VEGF treatment as retinal thickness decreases and nAMD-associated lesions improve. The extent of any such improvement in MS beyond 12 months is unknown.
III. Discussion
The quality of evidence varied among the 52 articles. Overall, none of the RCTs directly analysed the utility of microperimetry in the assessment of visual function in AMD but, as would be expected, evaluated a specific medical therapy using microperimetry as one of various outcome measures. Over half of the studies included in this review were observational in design and, therefore, have a consequent risk of selection bias, information bias, or confounding bias 26 . Many studies had limitations in the quality of reporting of the microperimetry outcomes and/or of the SD-OCT methods and analysis (Table 1) . Comparison between studies was also confounded by the differences in the classification systems for early and intermediate AMD. Four studies did not include the classification method 5, 23, 28, 38 . An additional difficulty in comparing studies arose from the differences in the dynamic range between the various microperimeters used in the studies.
The majority of studies used the summary statistic MS, which is not age-corrected, and many of the studies did not report either the number or the spatial location of the stimuli upon which the MS was based 4, 6, 16, 22, 32, 33, 39, 41, 45, 52 . Only 12 of the studies analysed the DLS at each given stimulus location 28, 38, 53, 57, [60] [61] [62] [63] 65, [72] [73] [74] . From the 52 included studies, two of the studies 3, 16 utilised location-specific probability analysis of the measured DLS compared to the corresponding age-corrected normal value, as is conventional practice in SAP. Despite the latter probability analysis enabling separation of focal from diffuse defects 31 , such an approach was not utilised in these two studies.
The absence of a robust statistical analysis software package for microperimetry that would separate focal from diffuse loss and that is comparable to that widely used in SAP currently limits the usefulness of the technique. Such analysis would enable a more clinically relevant evaluation of the microperimetry outcomes, particularly their association with structure. The various microperimeter manufacturers should be encouraged to develop such a package to allow this more comprehensive method of assessing abnormal visual function. In late stage AMD, this type of analysis would also need to be corrected for the presence for any retinal locus 14 .
The clinical value of microperimetry has not yet been assessed against other functional biomarkers of AMD, such as flicker sensitivity and dark adaptation, known to be sensitive to AMD disease severity 15, 47 Microperimetry offers detailed topographical information relative to traditional measures of foveal function such as VA and CS. In addition, microperimetry was superior to VA in detection of subtle AMD changes in a longitudinal study over one year 72 .
The investigation of microperimetry in comparison with dark adaptation in early AMD would be of value and enable clearer clinical recommendations for microperimetry.
Notwithstanding the above limitations, it is clear that there is a strong association between the magnitude of the DLS and a number of classic signs associated with AMD. Disruptions of the EZ band and RPE are associated with reduced DLS despite the maintenance of good VA 29, 34, 38, 49, 74 . OS thinning and RPE thickening are both associated with reduced MS, in early AMD 3 . A thickening and a thinning of the whole retina in CNV are each associated with a reduced MS 4, 29, 55 .
IV. Conclusion
The current microperimetric literature is of varying quality, but has been improving in recent 
V. Methods of literature search
The Medline, Ovid, EMBASE and Web of science databases were each searched using the search terms in Table 2 . The search extended from 1950 (Medline only) to November 2016.
The search terms were divided into two groups: population and instrument (Table 2) . Each selected article was required to match at least one search term from each group. Additional articles were identified from the references within the publications identified by the primary search. The abstracts of articles found from the database search were independently assessed by two of the authors (NC and JA) to identify those that met the inclusion criteria.
Eligible articles had to include microperimetry undertaken on at least twenty eyes with AMD to provide a minimum level of evidence. All articles were required to contain the DLS outcome obtained by microperimetry. Preferred retinal location and fixation studies were excluded. Only articles that discussed microperimetry in the context of the outcome from other commercially available instrumentation were included. Conference abstracts and case reports were excluded. Studies where the whole article was not written in English were also excluded.
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